Form 4: Exact Sciences CEO Kevin Conroy Reports Stock Transactions
SEC Form 4 Filing
Kevin Conroy, CEO of Exact Sciences, reports transactions involving common stock and restricted stock units, including acquisitions and disposals for tax withholding.
Summary
- On February 19, 2025, Kevin Conroy acquired 10,374 shares of common stock upon vesting of restricted stock units and disposed of 3,271 shares for tax withholding at a price of $49.63.
- On February 20, 2025, he acquired 48,044 shares of common stock upon settlement of a performance share unit award and disposed of 21,140 shares for tax withholding at a price of $50.48.
- Following these transactions, Conroy directly owns 1,108,198 shares of common stock.
- He also indirectly owns shares through a 401(k) plan and Grantor Retained Annuity Trusts.
- Conroy holds an additional 672,645 vested and unvested options to purchase shares of common stock and restricted stock units.
Sentiment
Score: 6
Explanation: The sentiment is neutral. The filing reflects routine transactions related to executive compensation. There is no indication of unusual activity or concern.
Positives
- The acquisition of shares through vesting of restricted stock units and settlement of performance share units indicates confidence in the company's performance.
Industry Context
Form 4 filings are standard practice for company insiders and provide transparency into their transactions, which can be indicative of their sentiment towards the company's prospects.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in the CEO's holdings, but the overall impact is likely minimal.
Key Dates
| Date | Description |
|---|---|
| 02/19/2021 | Date of restricted stock unit award that vests in four equal annual installments |
| 02/19/2025 | Acquisition of common stock upon vesting of restricted stock units; disposal of shares for tax withholding |
| 02/20/2025 | Acquisition of common stock upon settlement of performance share unit award; disposal of shares for tax withholding |
| 02/21/2025 | Date of signature by attorney-in-fact |
Keywords
Exact Sciences, EXAS, Kevin Conroy, Form 4, Stock Transactions, Restricted Stock Units, Performance Share Units, Beneficial Ownership, Tax Withholding
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.